| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.077 | 0.08 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |